Collectively, these data can support the conclusion that FBXL7 reduced the expression of PFKFB4, thereby arresting glucose metabolism and the resultant malignant phenotype of NSCLC cells. The gene discussed is FBXL7; the disease is non-small cell lung carcinoma.